Next Article in Journal
HSF1 Regulates Mevalonate and Cholesterol Biosynthesis Pathways
Next Article in Special Issue
Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma—Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice
Previous Article in Journal
In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome
Previous Article in Special Issue
New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
 
 

Order Article Reprints

Journal: Cancers, 2019
Volume: 11
Number: 1362

Article: CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
Authors: by Shigeki Suemura, Takahiro Kodama, Yuta Myojin, Ryoko Yamada, Minoru Shigekawa, Hayato Hikita, Ryotaro Sakamori, Tomohide Tatsumi and Tetsuo Takehara
Link: https://www.mdpi.com/2072-6694/11/9/1362

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Shipping Address

Billing Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop